Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Brian J. Sandri, Adam Kaplan, Shane W. Hodgson, Mark Peterson, Svetlana Avdulov, LeeAnn Higgins, Todd Markowski, Ping Yang, Andrew H. Limper, Timothy J. Griffin, Peter Bitterman, Eric F. Lock, Chris H. Wendt. Multi-omic molecular profiling of lung cancer in COPD. Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017

Member's Comments

No comment yet.

Related content which might interest you: Analysis and comparison of the transcriptome of COPD patients with and without lung cancer Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Metabolomics in lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Epigenetics in IPF and lung cancer Source: Research Seminar 2015 Year: 2015 DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Airway gene expression as a link between COPD and lung cancer Source: Annual Congress 2009 - The lung cancer-COPD nexus Year: 2009 Validation of diagnostic molecular markers in bronchial fluid for lung cancer Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Identifying a tissue specific microRNA molecular signature in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Early detection of lung cancer in patients with COPD by eNose technology Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006 BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers Source: Eur Respir J 2015; 45: 1403-1414 Year: 2015